<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <title>FOOTNOTES</title>
 <fn fn-type="other">
  <p>
   <def-list>
    <title>GLOSSARY</title>
    <def-item>
     <term>ARDS</term>
     <def>
      <p>xxx</p>
     </def>
    </def-item>
    <def-item>
     <term>BTLA</term>
     <def>
      <p>B- and T-lymphocyte attenuator</p>
     </def>
    </def-item>
    <def-item>
     <term>CD</term>
     <def>
      <p>cluster of differentiation</p>
     </def>
    </def-item>
    <def-item>
     <term>COVID-19</term>
     <def>
      <p>coronavirus disease 2019</p>
     </def>
    </def-item>
    <def-item>
     <term>CTLA-4</term>
     <def>
      <p>cytotoxic T-lymphocyte antigen 4</p>
     </def>
    </def-item>
    <def-item>
     <term>H1N1</term>
     <def>
      <p>hemagglutinin type 1 and neuraminidase type 1 (influenza strain)</p>
     </def>
    </def-item>
    <def-item>
     <term>HLA</term>
     <def>
      <p>human leukocyte antigen</p>
     </def>
    </def-item>
    <def-item>
     <term>HLA-B*15:03</term>
     <def>
      <p>xxx</p>
     </def>
    </def-item>
    <def-item>
     <term>ICU</term>
     <def>
      <p>intensive care unit</p>
     </def>
    </def-item>
    <def-item>
     <term>MÐ¤</term>
     <def>
      <p>macrophages</p>
     </def>
    </def-item>
    <def-item>
     <term>MAVS</term>
     <def>
      <p>mitochondrial antiviral signaling</p>
     </def>
    </def-item>
    <def-item>
     <term>mHLA-DR</term>
     <def>
      <p>monocytic human leukocyte antigen-DR</p>
     </def>
    </def-item>
    <def-item>
     <term>PD-1</term>
     <def>
      <p>programmed death 1</p>
     </def>
    </def-item>
    <def-item>
     <term>PD-L1</term>
     <def>
      <p>programmed death 1 ligand</p>
     </def>
    </def-item>
    <def-item>
     <term>SARS-CoV2</term>
     <def>
      <p>severe acute respiratory syndrome coronavirus 2</p>
     </def>
    </def-item>
    <def-item>
     <term>T1DM</term>
     <def>
      <p>type 1 diabetes mellitus</p>
     </def>
    </def-item>
    <def-item>
     <term>T2DM</term>
     <def>
      <p>type 2 diabetes mellitus</p>
     </def>
    </def-item>
    <def-item>
     <term>TH17</term>
     <def>
      <p>xxx</p>
     </def>
    </def-item>
   </def-list>
  </p>
 </fn>
 <fn fn-type="financial-disclosure">
  <p>Funding: This work was supported by grants from US Department of Defense (W81XWH-17-1-0577 [to J.W.Z]) and National Institutes of Health (NIH) (R01 HL139617-01 [to J.W.Z]).</p>
 </fn>
 <fn fn-type="COI-statement">
  <p>The authors declare no conflicts of interest.</p>
 </fn>
 <fn fn-type="other">
  <p>Reprints will not be available from the authors.</p>
 </fn>
</fn-group>
